U C Tripathi1, S B Nagaraja2, J P Tripathy3, S K Sahu4, M Parmar5, K Rade6, S Bhatnagar7, A Ranjan8, K S Sachdeva9. 1. World Health Organization (WHO), Revised National Tuberculosis Control Programme (RNTCP) Technical Support Network, Lucknow, India. 2. Employees State Insurance Corporation Medical College and Post Graduate Institute of Medical Sciences & Research, Bangalore, India. 3. School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India. 4. Jawaharlal Institute of Post-Graduate Medical Education and Research, Pondicherry, India. 5. WHO Country Office for India, New Delhi, India. 6. WHO-RNTCP Technical Support Network, Central TB Division (CTD), Directorate General of Health Services, New Delhi, India. 7. State TB Demonstration and Training Centre, Agra, India. 8. State TB Cell, Medical & Health Directorate, Lucknow, India. 9. CTD, Directorate General of Health Services, New Delhi, India.
Abstract
SETTING: All multidrug-resistant tuberculosis (MDR-TB) patients who had completed 6 months of treatment under the Revised National Tuberculosis Control Programme (RNTCP) in Uttar Pradesh, the largest state in northern India. OBJECTIVE: To determine the proportion of MDR-TB patients with regular follow-up examinations, and underlying provider and patient perspectives of follow-up services. METHODS: A retrospective cohort study was undertaken involving record reviews of 64 eligible MDR-TB patients registered during April-June 2013 in 11 districts of the state. Patients and programme personnel from the selected districts were interviewed using a semi-structured questionnaire. RESULTS: A total of 34 (53.1%) patients underwent follow-up sputum culture at month 3, 43 (67.2%) at month 4, 36 (56.3%) at month 5 and 37 (57.8%) at month 6. Themes associated with irregular follow-up that emerged from the interviews were multiple visits, long travel distances, shortages of equipment at the facility and lack of knowledge among patients regarding the follow-up schedule. CONCLUSION: The majority of the MDR-TB patients had irregular follow-up visits. Provider-related factors outweigh patient-related factors on the poor follow-up examinations. The programme should focus on the decentralisation of follow-up services and ensure logistics and patient-centred counselling to improve the regularisation of follow up.
SETTING: All multidrug-resistant tuberculosis (MDR-TB) patients who had completed 6 months of treatment under the Revised National Tuberculosis Control Programme (RNTCP) in Uttar Pradesh, the largest state in northern India. OBJECTIVE: To determine the proportion of MDR-TB patients with regular follow-up examinations, and underlying provider and patient perspectives of follow-up services. METHODS: A retrospective cohort study was undertaken involving record reviews of 64 eligible MDR-TB patients registered during April-June 2013 in 11 districts of the state. Patients and programme personnel from the selected districts were interviewed using a semi-structured questionnaire. RESULTS: A total of 34 (53.1%) patients underwent follow-up sputum culture at month 3, 43 (67.2%) at month 4, 36 (56.3%) at month 5 and 37 (57.8%) at month 6. Themes associated with irregular follow-up that emerged from the interviews were multiple visits, long travel distances, shortages of equipment at the facility and lack of knowledge among patients regarding the follow-up schedule. CONCLUSION: The majority of the MDR-TB patients had irregular follow-up visits. Provider-related factors outweigh patient-related factors on the poor follow-up examinations. The programme should focus on the decentralisation of follow-up services and ensure logistics and patient-centred counselling to improve the regularisation of follow up.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Bull World Health Organ Date: 2007-11 Impact factor: 9.408
Authors: Ma Tarcela Gler; Ruffy Guilatco; Janice C Caoili; Julia Ershova; Peter Cegielski; John L Johnson Journal: Am J Trop Med Hyg Date: 2013-09-09 Impact factor: 2.345
Authors: Timothy H Holtz; Maya Sternberg; Steve Kammerer; Kayla F Laserson; Vija Riekstina; Evija Zarovska; Vija Skripconoka; Charles D Wells; Vaira Leimane Journal: Ann Intern Med Date: 2006-05-02 Impact factor: 25.391
Authors: M D Morris; L Quezada; P Bhat; K Moser; J Smith; H Perez; R Laniado-Laborin; J Estrada-Guzman; T C Rodwell Journal: Int J Tuberc Lung Dis Date: 2013-07 Impact factor: 2.373